EIF2AK4, eukaryotic translation initiation factor 2 alpha kinase 4, 440275
N. diseases: 89; N. variants: 35
Source: ALL
Disease | Type | Disease Class | Semantic Type | N. genes d | N. SNPs d | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
disease | Respiratory Tract Diseases; Cardiovascular Diseases | Disease or Syndrome | 8 | 3 | 0.100 | None | 1.000 | 12 | 1 | 2014 | 2020 | ||||
|
group | Neoplasms | Neoplastic Process | 10161 | 1644 | 0.050 | None | 0.800 | 5 | 2015 | 2019 | |||||
|
group | Neoplasms | Neoplastic Process | 8621 | 1641 | 0.040 | None | 1.000 | 4 | 2013 | 2019 | |||||
|
group | Cardiovascular Diseases | Disease or Syndrome | 2322 | 1085 | 0.040 | None | 1.000 | 4 | 2014 | 2020 | |||||
|
group | Neoplasms | Neoplastic Process | 8221 | 1374 | 0.040 | None | 1.000 | 4 | 2013 | 2019 | |||||
|
disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | Neoplastic Process | 1293 | 222 | 0.030 | None | 1.000 | 3 | 2018 | 2019 | |||||
|
phenotype | Clinical Attribute | 843 | 1931 | 0.100 | None | 1.000 | 3 | 2 | 2017 | 2019 | |||||
|
phenotype | Laboratory or Test Result | 593 | 988 | 0.100 | None | 1.000 | 3 | 2 | 2016 | 2019 | |||||
|
phenotype | Laboratory Procedure | 593 | 988 | 0.100 | None | 1.000 | 3 | 2 | 2016 | 2019 | |||||
|
disease | Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | Disease or Syndrome | 2821 | 1111 | 0.020 | None | 1.000 | 2 | 2014 | 2019 | |||||
|
phenotype | Finding | 653 | 1206 | 0.100 | None | 1.000 | 2 | 2 | 2016 | 2019 | |||||
|
disease | Neoplasms | Neoplastic Process | 3087 | 515 | 0.020 | None | 1.000 | 2 | 2015 | 2019 | |||||
|
disease | Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases | Neoplastic Process | 1096 | 261 | 0.020 | None | 1.000 | 2 | 2018 | 2019 | |||||
|
group | Infections | Disease or Syndrome | 1471 | 42 | 0.020 | None | 1.000 | 2 | 2006 | 2017 | |||||
|
disease | Neoplastic Process | 860 | 154 | 0.020 | None | 1.000 | 2 | 2018 | 2019 | ||||||
|
disease | Disease or Syndrome | 1 | 0.020 | None | 1.000 | 2 | 2017 | 2017 | |||||||
|
disease | Digestive System Diseases; Neoplasms | Neoplastic Process | 5473 | 1962 | 0.020 | None | 1.000 | 2 | 2015 | 2019 | |||||
|
disease | Nervous System Diseases; Mental Disorders | Disease or Syndrome | 3397 | 1843 | 0.020 | None | 1.000 | 2 | 2013 | 2013 | |||||
|
disease | Neoplasms; Female Urogenital Diseases and Pregnancy Complications | Neoplastic Process | 1597 | 326 | 0.100 | None | 1.000 | 2 | 1 | 2016 | 2018 | ||||
|
disease | Pathological Conditions, Signs and Symptoms; Neoplasms | Neoplastic Process | 2825 | 188 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | |||||
|
phenotype | Clinical Attribute | 1014 | 2689 | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | |||||
|
disease | Digestive System Diseases | Disease or Syndrome | 1058 | 222 | 0.010 | None | 1.000 | 1 | 2018 | 2018 | |||||
|
disease | Neoplasms | Neoplastic Process | 724 | 22 | 0.010 | None | 1.000 | 1 | 2020 | 2020 | |||||
|
phenotype | Clinical Attribute | 507 | 1037 | 0.100 | None | 1.000 | 1 | 1 | 2017 | 2017 | |||||
|
group | Neoplasms | Neoplastic Process | 853 | 42 | 0.010 | None | < 0.001 | 1 | 2015 | 2015 |